Pulmonary Cytopathology: Current and Future Impact on Patient Care.
Surg Pathol Clin
; 17(3): 395-410, 2024 Sep.
Article
en En
| MEDLINE
| ID: mdl-39129139
ABSTRACT
Small biopsies of lung are routinely obtained by many methods, including several that result in cytologic specimens. Because lung cancer is often diagnosed at a stage for which primary resection is not an option, it is critical that all diagnostic, predictive, and prognostic information be derived from such small biopsy specimens. As the number of available diagnostic and predictive markers expands, cytopathologists must familiarize themselves with current requirements for specimen acquisition, handling, results reporting, and molecular and other ancillary testing, all of which are reviewed here.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Neoplasias Pulmonares
Límite:
Humans
Idioma:
En
Revista:
Surg Pathol Clin
Año:
2024
Tipo del documento:
Article
Pais de publicación:
Estados Unidos